Reply to: Correspondence on ‘Concordance of ctDNA and tissue genomic profiling in advanced biliary tract cancer’

IF 26.8 1区医学 Q1 GASTROENTEROLOGY & HEPATOLOGY

Journal of Hepatology Pub Date : 2025-02-12 DOI:10.1016/j.jhep.2025.02.006

Sohyun Hwang, Seonjeong Woo, Chan Kim, Hong Jae Chon

{"title":"Reply to: Correspondence on ‘Concordance of ctDNA and tissue genomic profiling in advanced biliary tract cancer’","authors":"Sohyun Hwang, Seonjeong Woo, Chan Kim, Hong Jae Chon","doi":"10.1016/j.jhep.2025.02.006","DOIUrl":null,"url":null,"abstract":"<h2>Section snippets</h2><section><section><h2>Authors’ contributions</h2>Sohyun Hwang and Seonjeong Woo: Study design & Manuscript writing.Chan Kim and Hong Jae Chon: Study design & Manuscript revision.</section></section><section><section><h2>Uncited reference</h2>6..</section></section><section><section><h2>Financial support</h2>This research was funded by the National Research Foundation of Korea (NRF) grants, supported by the Korean government (MSIT): grant numbers NRF-2023R1A2C2004339 to Hong Jae Chon, NRF-2023R1A2C2006375 to Chan Kim, and NRF-2019R1A6A1A03032888 to Sohyun Hwang.</section></section><section><section><h2>Declaration of Competing Interest</h2>Hong Jae Chon holds consulting or advisory roles with Eisai, Roche, Bayer, ONO, MSD, BMS, Celgene, Sanofi, Servier, AstraZeneca, SillaJen, Menarini, and GreenCross Cell, and has received research grants from Roche, Dong-A ST, and Boryung Pharmaceuticals. Chan Kim is involved in consulting or advisory capacities with Roche, ONO, MSD, BMS, Oncocross, and Virocure, and has received research funding from Boryung Pharmaceuticals, Oncocross, SillaJen, and Virocure. The remaining authors declare no</section></section>","PeriodicalId":15888,"journal":{"name":"Journal of Hepatology","volume":"78 5 Pt 1 1","pages":""},"PeriodicalIF":26.8000,"publicationDate":"2025-02-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Hepatology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.jhep.2025.02.006","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Section snippets

Authors’ contributions

Sohyun Hwang and Seonjeong Woo: Study design & Manuscript writing.Chan Kim and Hong Jae Chon: Study design & Manuscript revision.

Uncited reference

6..

Financial support

This research was funded by the National Research Foundation of Korea (NRF) grants, supported by the Korean government (MSIT): grant numbers NRF-2023R1A2C2004339 to Hong Jae Chon, NRF-2023R1A2C2006375 to Chan Kim, and NRF-2019R1A6A1A03032888 to Sohyun Hwang.

Declaration of Competing Interest

Hong Jae Chon holds consulting or advisory roles with Eisai, Roche, Bayer, ONO, MSD, BMS, Celgene, Sanofi, Servier, AstraZeneca, SillaJen, Menarini, and GreenCross Cell, and has received research grants from Roche, Dong-A ST, and Boryung Pharmaceuticals. Chan Kim is involved in consulting or advisory capacities with Roche, ONO, MSD, BMS, Oncocross, and Virocure, and has received research funding from Boryung Pharmaceuticals, Oncocross, SillaJen, and Virocure. The remaining authors declare no

查看原文本刊更多论文

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of Hepatology 医学-胃肠肝病学

CiteScore

46.10

自引率

4.30%

发文量

2325

审稿时长

30 days

期刊介绍： The Journal of Hepatology is the official publication of the European Association for the Study of the Liver (EASL). It is dedicated to presenting clinical and basic research in the field of hepatology through original papers, reviews, case reports, and letters to the Editor. The Journal is published in English and may consider supplements that pass an editorial review.